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Background: Among the most burdensome clinical conditions occurring in older persons, respiratory infections are
particularly relevant. In fact, the onset of pneumonias is associated with a significant worsening of the individual’s
global health status and significant increase of healthcare costs. The clinical and economical negative consequences
of pneumonia may be particularly evident among the frailest groups of elders, in particular those living in nursing
home. Nevertheless, specific research on incidence and economical effects of pneumonia in nursing homes
residents is still scarce. In the present article, we present the rationale, the design and the methods of the
“Incidence of pNeumonia and related ConseqUences in nursing home Resident (INCUR) study, specifically aimed at
filling some of the gaps currently present in the field.
Methods/design: INCUR is an observational longitudinal study recruiting 800 residents across 13 randomly selected
nursing homes in France. Multidimensional evaluations of participants are conducted at the baseline, mid-term (at
6 months), and end of the study (at 12 months) visits in order to measure and follow-up their physical function,
nutrition, cognition, depression, quality of life, and healthcare costs. Incident pneumonia as well as the onset/
recurrence of other major health-related events are monitored during the study follow-up.
Discussion: The INCUR study will provide valuable information about older persons living in nursing homes. Results
from INCUR study may constitute the basis for the development of future preventive campaigns against
pneumonia and its consequences.
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Over the past years, the number and prevalence of
older persons in industrialized countries have steadily
grown [1]. Consistently, the number of people living in
nursing home is also increased and is expected to fur-
ther rise. To date, in the United States, there are about
~16,100 nursing homes with ~1.5 million residents for
~314 million inhabitants [2]. The projected national
cost of nursing home for 2000 exceeded $140 billion,
but may exceed $700 billion by 2030 [3]. In France,
about 700,000 persons (representing 1.2% of the na-
tional population) [4] currently live in ~10 000 nursing* Correspondence: cesari.m@chu-toulouse.fr
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distribution, and reproduction in any mediumhomes [2]. Unfortunately, research in nursing homes is
still scarce. It has been estimated that only 2% of stud-
ies in the geriatrics are carried out in this specific set-
ting [4] which is not only characterized by a steady
expansion, but is also particularly burdensome for the
healthcare system.
The lack of research in nursing home may be easily
explained by the complexity and heterogeneity of the
older persons living in this setting and their limited
access to study protocols [5,6]. The vast majority of
nursing home residents is characterized by the most
dramatic results of the pathophysiological modifications
and chronic conditions experienced and accumulated
during the entire life course. The complexity of nursing
home residents is due to the high comorbidity [7,8], thentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tropic drugs [9]) [10] the presence of major geriatric
syndromes (e.g., falls [11]), and the general poor health
status (e.g., malnutrition [12]). In particular, it cannot
be ignored that the high prevalence of physical disabil-
ity in this population. Fried and colleagues [13] calcu-
lated that although older persons represent only the
19% of the entire United States population, their
healthcare needs demand almost half of the public
health budget. Such economical estimation was largely
influenced by the presence of disabling conditions.
Both the increasing number of nursing home residents
and the heavy burden they impose to public health ex-
penditures make the study of this population a research
priority in order to design and hopefully implement fu-
ture ad hoc preventive and therapeutical interventions.
Any acute illness (in particular, respiratory conditions
[14]) negatively affects physical function of older persons
[15]. Therefore, the prevention of physical disability (the
primary aim of geriatric medicine) may necessarily imply
the need to consider preventive interventions targeting
specific acute clinical conditions. The implementation of
preventive campaigns is important for the subject (who
may reduce the own risk of experiencing the disease) as
well as for the healthcare system (which may signifi-
cantly save resources).
It is possible that the frail older persons living in nurs-
ing homes may be specially amenable of beneficiating
from preventive interventions and protocols [16]. In fact,
the high risk of health-related events and complications
to which this population is exposed may reduce the
cost-effectiveness ratio of a preventive protocol. Interest-
ingly, the same protocol may differently be unfeasible in
community-dwelling subjects because a too large num-
ber of persons should receive the intervention in order
to gain significant benefits. Moreover, a limited improve-
ment (or even the avoidance of health loss) in a frail
older person may have relevant effects for public health,
given the exponential relationship between healthcare
costs and physical function [13].
Although the incidence of infectious diseases has
been largely decreasing in young and adult persons in
Western Countries over the last century, similar trends
have not been reported in older persons [17-20]. The
atypical presentations of infections at advanced age
(including lack of fever, behavioral changes, confusion)
are responsible for diagnostic difficulties resulting in
incorrect therapeutical prescriptions. For example, it
has been reported that a significant proportion of anti-
biotics use is not justified or not adequately prescribed
in nursing homes [21,22]. The erroneous use of antibi-
otics contributes not only to generate bacterial resis-
tances, but also increases direct and indirect costs
[21,23].Most of the observational studies estimating the in-
cidence and effects of infectious diseases has been
performed at the community level. Limited evidence
on this topic is currently available in nursing homes
and long-term care facilities which generally host
older persons with higher morbidity and increased
mortality risk [20,24]. Moreover, as suggested by the
large variations of prevalence and incidence rates
available in literature (mainly due to differences in
methodological approaches, intensity of surveillance,
case mix, and facility administration [25]), data from
these healthcare settings are far to be definitive. Just
to provide few examples about the relevance of the
(currently underestimated) phenomenon in nursing
home: it has been calculated that the prevalence of
infections (i.e., respiratory, cutaneous, and urinary) in
institutionalized older persons may range from 1.6%
to 32%, and the overall incidence rates vary from 1.8
to 13.5 infections per 1,000 residents-year [26]. These
figures are at least 10-fold higher than those reported
in community-dwelling older persons [27]. In this
context, the respiratory system is one of the most
frequently affected sites for infections. The incidence
of nursing home-acquired pneumonia in the United
States varies between 0.3 and 2.3 episodes per 1,000
resident-days [25]. In a recent paper, Ahmed and col-
leagues [28] explored the hospitalization events occur-
ring among nursing home residents in the United
States, finding that pneumonia was the leading pri-
mary discharge diagnosis from the hospital (6%) and
a major predictor of in-hospital mortality.
The purpose of the present article is to present the
design and methodological approach of the “Incidence
of pNeumonia and related ConseqUences in nursing
home Resident” (INCUR) study. INCUR is an obser-
vational longitudinal cohort study aimed at estimating
the incidence and economical effects of pneumonia in
older persons living in nursing homes (i.e., Etablissement
d’Hébergement pour Personnes Agées Dépendantes, EHPAD)
in France.The INCUR study
Hypotheses and objectives
The INCUR project is specifically aimed at retrieving
data from routine clinical practice in order to esti-
mate the incidence of pneumonia events in older per-
sons living in a sample of French nursing homes.
Moreover, INCUR is designed to estimate the clinical
and economical consequences of pneumonia events
by measuring the subsequent access to medical proce-
dures and resources. More in details, the following
hypotheses have driven the rationale and conception
of the INCUR project:
Table 1 Inclusion and exclusion criteria of the
INCUR study
Inclusion
criteria
- Residents aged 60 years and older
- Groupes Iso-Ressources (GIR) ranging between 2
(included) and 5 (included). This is the French
administrative tool used to rate the ability of the person
to be independent; it ranges from 6 (fully independent)
to 1 (fully dependent, bed-ridden)
Exclusion
criteria
- Residents living in the participating nursing homes for
less than 30 days since the baseline study visit
- Refusal of the patient and/or the family to participate at
the INCUR project
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a. Pneumonia is a clinical condition frequently
complicating the nursing home stay of older persons;
Secondary hypotheses:
a. The onset of a pneumonia event in institutionalized
older residents is associated with higher
healthcare costs;
b. Incident pneumonia events are associated with an
increased risk of mortality in older persons living in
nursing home;
c. The onset of a pneumonia event is responsible for a
significant worsening of the physical function of
nursing home residents;
Tertiary hypotheses:
a. Specific variables at patient- and nursing home-level
may predict the severity of the pneumonia-related
functional loss;
b. Nursing home residents dying due to pneumonia
produce a significantly higher burden in terms of
healthcare costs compared to nursing home
residents dying for other causes.
Therefore, the INCUR project will pursue the follow-
ing aims:
Primary aims:
a. To estimate the incidence of pneumonia events in a
sample of older nursing home persons over a period
of 12 months;
Secondary aims:
a. To compare the healthcare costs of nursing home
older persons experiencing a pneumonia event versus
those who will not over a period of 12 months;
b. To calculate the mortality risk in a sample of older
residents living in nursing home according to the
presence/absence of a pneumonia event occurred
during a follow-up period of 12 months;
c. To measure the physical function modifications
experienced by a sample of nursing home residents
according to the presence/absence of a pneumonia
event occurred during a follow-up period of
12 months;
Tertiary aims:
a. To identify sociodemographic, clinical, and
biological characteristics of nursing home olderresidents, as well as environmental and organizational
factors of their own hosting institution, which are
associated with a higher degree of functional loss
following a pneumonia event;
b. To explore whether mortality due to pneumonia is
associated with higher healthcare costs compared to
death events due to non-respiratory causes in
nursing home older residents.
Methods/design
For the INCUR project, we recruited 800 residents of 13
nursing homes randomly selected in the Midi-Pyrénées
region of France. In particular, nursing homes of the re-
gion were consecutively and randomly invited at partici-
pating in INCUR. After each nursing home accepted to
be involved in the study, all its residents (according to
their eligibility for INCUR) were assessed by the study
personnel. The recruitment was conducted up to the
reaching of the final sample of 800 participants according
to the predefined sample size analyses (see specific
paragraph). All the nursing homes were part of a
national network of institutions representative of this
healthcare in France [4]. To be part of the project, the
director, the coordinating physician, and the responsible
for the nursing of each institution signed a formal
agreement and letter of support.
The main inclusion and exclusion criteria were the
constituted by the score obtained by the participant at
the Autonomie Gérontologie - Groupes Iso-Ressources
(AGGIR) scale (Table 1). This scale allows to homoge-
neously generate six Groupes Iso-Ressources (GIR) at the
French national level. The resulting GIR expresses the
global functional capacity of the person and drives deci-
sions about the provision of social support from public
healthcare system. Subjects with severe disability are ex-
cluded from INCUR on the basis of the worst GIR group
(i.e., 1). The reason for such exclusion resides in the
impossibility to determine in these patients the weight
of functional loss due to a pneumonia event (primary
aim d). Similarly, residents with no sign of functional
impairment at the AGGIR scale (that is having the
maximum GIR score of 6) are excluded due to the
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over the follow-up.
Each eligible participant will be followed-up for
12 months with a total of three clinical assessments: at
baseline, 6 months (mid-term visit), and 12 months
(close-out visit). The timeline of the INCUR project is
depicted in Figure 1. Recruitment of participants and
baseline visits began in February 2012 and ended in July
2012, after a preliminary organization phase (for coord-
inating activities of researcher with the participating
nursing homes). The mid-term visit of participants (after
6 months of follow-up) is currently ongoing.
The INCUR visits are conducted by research staff spe-
cifically trained at the Gérontopôle of Toulouse. The
evaluations will be conducted using multiple scales,
questionnaires and tests based on the Geriatric Mini-
mum Data Set (GMDS) [29], thus allowing a compre-
hensive assessment of participants. The GMDS is a
package of assessment tools designed by a multidiscip-
linary task force group (i.e., the Gerontonet) [30], aimed
at evaluating the different areas of the person’s health,
including physical function, nutrition, cognition, depres-
sion, quality of life. As shown in Table 2, these include:
ADL [31], Instrumental ADL (IADL) [32], European
Quality of Life (EuroQoL) instrument [33], frailty pheno-
type proposed by Fried and colleagues [34], Abbreviated
Mental Test [35], 15-item Geriatric Depression Scale
[36], Mini Nutritional Assessment [37]. The GMDS in-
strument was originally conceived to promote the trans-
lation of routinely collected clinical parameters into
research data. Therefore, consistently with the descrip-
tive nature of the INCUR project, the items collected
will be primarily retrieved from the medical charts of
the participants (if present). Missing data will be com-
pleted by specific evaluations of the INCUR study staff.
The same standardized multidimensional assessment
performed at the baseline will then be repeated at the 6-
and 12-month follow-up visits. Additionally, the follow-up
visits will be specifically focused at identifying the onset of
major health-related events (in particular pneumonia)
occurred during the previous 6 months of follow-up. In
particular, the study staff will retrieve information about
major intercurrent illnesses, emergency room admissions,
hospitalizations, and death events (including causes) fromFigure 1 The timeline of the INCUR project.patient's medical records and charts, the nursing home
personnel, and the proxies of the participant. Moreover, in
between the follow-up visits, regular contacts between the
study staff and the nursing homes personnel will be
maintained in order to facilitate and improve the identifi-
cation of the health-related events experienced by the
INCUR participants.
To design and develop the INCUR study, the princi-
ples of the Declaration of Helsinki have been followed
and ethical standards complied. The Ethics Committee
of the Centre Hospitalier Universitaire de Toulouse and
the Consultative Committee for the Treatment of Re-
search Information on Health (CNIL) approved the en-
tire study protocol. The Ethics Committee waived the
need for written informed consent from the participants
given the epidemiological nature of the research within
the domain of current clinical practices. Therefore, par-
ticipants are not required to provide a written informed
to the study, but all participants receive written informa-
tion about the ongoing research (including its objectives
and procedures) by the study investigators. Residents are
then free to exclude their data from the collection or
analysis at any time. In case of residents with cognitive
impairment or unable to understand the research proto-
col, proxies are informed.
Pneumonia
From a clinical standpoint of view, it is difficult to obtain
a clear and definitive diagnosis of pneumonia in the
nursing homes population beacause of the multitude of
comorbidities (e.g., heart failure, chronic obstructive pul-
monary disease, pulmonary fibrosis) often altering the
manifestation of the respiratory infection. For example,
cough is often absent (even in more than 50% of the
cases), pulmonary crackles are rare, and the only reliable
criterion remains the increased respiratory rate. Such
difficulties combined with the limited access to comple-
mentary biological or imaging exams lead to unreliable
estimates for the diagnosis of pneumonia in the nursing
homes setting. To improve the diagnostic definition of
pneumonia, the Observatoire du Risque Infectieux en
Gériatrie (ORIG) [38] recently published specific criteria
refining those previously proposed by McGeer and col-
leagues [39]. The ORIG criteria described by Rothan-
Table 2 Main areas investigated and related instruments
adopted in the INCUR project
Area INCUR assessment
Sociodemographics
Body composition Anthropometric measures
Anamnesis/Comorbidity Current diseases
Medications
Vaccinations Influenza and pneumococcal vaccine
Cognition Abbreviated Mental Test
Geriatrics Depression Scale
Quality of life Euro-QoL 5D
Pain Pain Visuo-Analogic Scale
Functional Status Activities of Daily Living
Instrumental Activities of Daily Living
Short Physical Performance Battery
Hand grip strength
Nutrition Mini Nutritional Assessment
Healthcare cost Data from the Caisse Primaire d’Assurance
Maladie
Follow-up Intercurrent diseases
Therapy modifications
Hospitalization events
Death events and causes of death
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use in the nursing homes, taking into account the diag-
nostic difficulties characterizing this clinical setting.
Thus, the ORIG definition of a pneumonia event mirrors
the one based on the McGeer and colleagues’ algorithm
[39], but replace the most invasive and complex endo-
scopic and microbiological criteria with the physician’s
clinical judgement.
In the INCUR study, consistently with the ORIG prop-
osition, we will identify pneumonia events on the basis
of the following two criteria:
1. Presence of at least two of the following signs/
symptoms:
a. Worsening or onset of cough, purulent sputum,
or specific signs at the auscultation,
b. Fever (≥38°C),
c. Thoracic pain,
d. High respiratory rate (≥25 breaths per minute),
e. Mental confusion or worsening of physical
disability, and
2. Clinical evidence documented by a physician of
crackles at the thoracic auscultation.
It has been reported that the probable cases identified
using the ORIG definition are about 3.5-fold higher thanthe definitive cases of pneumonia identified using the
McGeer and colleagues criteria [39]. Surely, this latter
definition is more accurate and completely based on ob-
jective data. However, its difficult clinical implementa-
tion (especially in the nursing homes) and the large
difference in the identified cases of pneumonia (com-
pared to the ORIG definition) may be responsible for a
likely underestimation of the phenomenon and an inad-
equate capacity to be adapted to such healthcare setting.
Physical function measures
Physical function modifications will be determined by
repeated evaluations of several specific scales and ques-
tionnaires. In particular, we will use:
1. ADL scale [31]; The number of impaired ADLs was
calculated considering the following six tasks:
transferring from bed to chair, walking across a
room, eating, bathing, using the toilet and
personal hygiene.
2. IADL scale [32]; The assessment of impaired IADLs
was based on the evaluation of the following four
tasks: use of the telephone, use of transportations,
managing medications and managing finances.
3. Short Physical Performance Battery (SPPB) [40,41].
The SPPB is a physical performance test composed
by three timed subtasks: 4-meter usual gait speed,
balance, and chair stand tests. Timed results from
each test are scored from 0 (worst performers) to 4
(best performers) according to validated and
standardized cut-points [41]. Participants unable to
perform a specific SPPB subtest will result with a
score of 0 (or the 99th percentile) for that part of
the instrument. SPPB has shown to be associated
with subclinical (e.g., inflammation, vitamin D,
antioxidant status) [42,43] and clinical (e.g.,
comorbidity, disability, hospitalization,
institutionalization, mortality) [44,45] in
older persons;
4. Hand grip strength. It will be measured using a
hand-held dynamometer (model Jamar). Participants
will be asked to perform the task twice with each
hand. The average of the best results obtained at
each side will be used for the analyses. Hand grip
strength has shown to be predictive of health-related
events (including disability and mortality) [44,46-48];
5. Groupes Iso-Ressources (GIR). According to results
of this scale, a special allowance (i.e., Allocation
Personalisée d'Autonomie, APA) is allocated by the
Conseil Général to functionally impaired subjects
(scoring 4 or lower). Therefore, its significance is
beyond a pure evaluation of physical function, but
represents an easy and early indicator of the
healthcare cost of an older person.
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To address the second aim of the present project related
to the healthcare costs of pneumonia events in older
persons living in nursing homes, the INCUR project
will obtain specific data from the Caisse Primaire
d’Assurance Maladie (i.e., the French national healthcare
insurance system). In particular, the study coordinators
will receive the direct costs that the healthcare system
will sustain for each INCUR participant during the study
period. Such figures will include total and detailed
expenditures (including performed medical procedures,
medications consumption, access to specific healthcare
services…). As mentioned, specific parameters acting as
surrogated measures of healthcare expenditures will
also be directly retrieved during the INCUR clinical visits
from the participants’ medical records and charts by the
INCUR personnel. In particular, we will evaluate the fol-
lowing parameters: number and length of hospitalization
events, number of major medical procedures (including
admission and length of stay in Intensive Care Unit,
Orotracheal intubation, mechanical ventilation), and
transition to worse GIR classes. Although these (mainly
clinical) parameters may not provide the exact estimation
of the costs sustained by the healthcare system for the
patient, they still represent reliable markers of the eco-
nomical weight of the case. Moreover, since all these
procedures and events have direct and negative influences
on the older patient’s quality of life and functional sta-
tus, their significance goes well beyond a mere financial
evaluation. The collaboration with the CNAM will provide
us a detailed estimation of healthcare costs charged to the
public healthcare system for the management of INCUR
participants. Nevertheless, the main limitation of INCUR
in this context is represented by the impossibility to detect
and measure costs directly sustained by the participant
(and his/her family) and the impact of caregivers’ time
on societal aspects.
Sample size analyses
Mehr and colleagues [25] estimated that the incidence of
nursing home-acquired pneumonia in the United States
may range between 0.3 to 2.3 episodes per 1,000 resident-
days. In the present study, we expect to enroll 800 EHPAD
residents and follow them over a 12-month period (i.e., a
total of 292,000 resident-days). Considering the attrition
due to mortality (i.e., 20% per year in this setting4), we may
expect between 70.1 and 537.3 cases according to the
Meher and colleagues’ data [25]. More recently, Rothan-
Tondeur and colleagues [38] reported 311 infections in a
sample of 2,140 nursing home residents over a period of
28 days (from January 24 to February 20, 2005). The study
was conducted defining pneumonia according to the same
criteria we will implement in INCUR. Authors showed that
pneumonia represented the 7% of all the cases of infections(i.e., 22 events). Translating these figures over a 365-day
period (as proposed in the INCUR project) and sample size
we plan to recruit (i.e., 800 participants), we obtain 107.2
pneumonia events. It might happen that attrition due to
mortality (i.e., 20% per year4) and the spring-summer sea-
sons (during which the pneumonia events might be fewer;
i.e., additional 40% over 6 months) may further reduce such
estimation. However, we believe that, even in the worst case
scenario (i.e., 68.6 cases of pneumonia over one year, con-
sistent with the minimum estimation obtained from ana-
lyses performed on the Meher and colleagues’ data [25]), it
will be possible the evaluation of a sufficient number of
events to successfully accomplish the INCUR study aims.
The recruited sample size of 800 participants produces a
two-sided 98.2% or 95.2% confidence interval with a width
equal to 0,050 when the incidence of pneumonia are 10%
or 15%, respectively. Such incidence rates are overestimat-
ing the outcome of interest compared to the previous study
by Rothan-Tondeur et al [38]. (7%); thus, INCUR study is
adequately powered to accurately estimate the incidence of
pneumonia with the sample of 800 participants.
Analysis plan
All the analyses will consider an alpha value threshold
equal to 5% as determining the statistical significance.
Primary aims:
a. Taking into account the 12-month follow-up of the
study participants, we will detect all the participants
experiencing a new pneumonia event. The ratio
between the number of participants experiencing
one or more events and the number of participants
constituing the overall sample will provide the
incidence of pneumonia in the sample population.
Results will be presented as pneumonia cases per
1,000 resident-days, and as pneumonia events over
one year. Stratified analyses will be performed
according to age groups, gender, and pre-existing
pulmonary disease.
Secondary aims:
a. Primary independent variable of interest for the
present analyses will be the total expenditure (in
Euros) that participants will cost to the healthcare
system over the follow-up year. Additional
secondary analyses will also consider specific aspects
of the direct healthcare costs of INCUR participants
such as expenses due to hospitalizations or physical
therapy sessions. All these analyses will be stratified
and compared according to the presence/absence of
pneumonia events.
Unadjusted and adjusted analyses of covariance,
logistic regression models, and multinominal logistic
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means and risks of the outcome variables predicted
by the absence/presence of pneumonia events
occurred during the follow-up (dicothomous
independent variable of interest).
b. Participating patients will be divided in two groups,
according to the presence/absence of a pneumonia
event experienced during the follow-up period.
Then, the risk of death will be calculated and
compared between the two groups. Kaplan-Meier
survival curves will be provided according to
pneumonia events. Moreover, adjusted Cox
proportional hazard analyses taking into account
age, gender, pre-existing pulmonary disease, and
other possible confounders will be performed to
estimate the risk of dying in patients who
experienced a pneumonia versus those who did not.
Follow-up will be censored at the date of death for
patients dying during the follow-up, or to the last
contact date for those who did not.
c. When a pneumonia event will occur, physical
function information collected after its onset will be
compared to those previously recorded. The
difference in physical function measured before and
after the pneumonia event will be adjusted for the
days between the event onset and the following
physical function assessment. This analytical
approach will allow to take into account the negative
influence that the presence of a (sub)acute phase of
the respiratory process may exert on physical
function if the event will occur close to the
evaluation. Mixed effects analysis of covariance
models will also be performed to evaluate physical
function modifications over time between patients
who experienced a pneumonia event versus those
who did not. If statistical power will be sufficient,
stratified analyses will also be performed according
to the severity of the pneumonia event (e.g., events
requiring hospitalization versus those who did not).
For the present analyses, the sum of the results from
the three SPPB categorized tests (ranging from 0 [worst
physical performance] to 12 [best physical performance])
as well as the crude timed results obtained from each
single assessment (in seconds) will be used for the ana-
lyses. This will allow to evaluate whether the pneumonia
event will differently affect specific components of phys-
ical performance (i.e., balance, muscle strength, or gait/
coordination).
Tertiary aims:
a. Chi-square and t-test analyses will be performed to
describe the study population for main
sociodemographic, behavioral, and clinicalcharacteristics according to the presence/absence of
a pneumonia event occurred during the INCUR
project follow-up. Mann-Whitney U statistics will be
used for non-normally distributed continuous
variables. Normalization through log-transformation
will be used for non-normally distributed study
variables. Subsequent unadjusted and adjusted Cox
proportional hazard models will be analyzed to
identify patients’ characteristics that are able to
significantly predict pneumonia events (dependent
variable of interest). Among the covariates, age,
gender, race, and preexisting respiratory conditions
will always be considered as potential confounders.
Age, gender, and race interactions will be tested for
the studied relationships by adding specific
interaction terms into the models. If possible,
stratified analyses will be performed whereas
significant interactions will be obtained.
A similar analytical approach will be used to
evaluate specific characteristics of the EHPADs as
significant determinants of pneumonia events in
patients. EHPADs and patients’ characteristics might
be combined in secondary analyses to evaluate the
additive value of specific parameters towards the
onset of pneumonia events.
b. We will perform restricted analyses in participants
who will die during the follow-up (expected
mortality about 20% over 12 months, that is 160
fatal events in our sample population). This
subsample of participants will be divided according
to the cause of death (i.e., pneumoniarelated versus
other causes [expected number of cases 11.2 versus
158.8 according to Rothan- Tondeur et al [38]).
Chi-square and t-test analyses will be performed to
verify whether significant differences between
patients dying because of a pneumonia event versus
those dying for other causes exist for the following
healthcare parameters: - Total expenditure (in
Euros) that participants will cost to the healthcare
system over the follow-up period. This datum will
be obtained by the Gerontopôle from the Caisse
Primaire d’Assurance Maladie, which has allowed
the specific and exclusive release of it to the
CHUToulouse. Additional analyses will also consider
specific aspects of the direct healthcare costs of
INCUR participants such as expenses due to
hospitalizations or physical therapy sessions.
Mann-Whitney U statistics will be used for non-normally
distributed continuous variables. Normalization through
log-transformation will be used for non-normally distrib-
uted study variables. These analyses will consider the entire
follow-up period available. Secondary analyses will also be
restricted to consider the last month preceding the fatal
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hypothesized higher healthcare costs of pneumonia events
leading to death are distributed over time, or compressed
in the very last period of life. If the statistical power will be
sufficient, additional adjusted logistic and linear regression
models will be performed taking into account potential
confounders.
Quality control
The quality and eventual acceptance of all studies depend
on issues such as: maintaining randomization integrity,
accurately assessing participant eligibility, recording drop-
outs and adherence, measuring outcome variables without
bias, preventing premature release of results, monitoring
and assessing protocol adherence, and avoiding biases
in the analysis of the results. Quality control proce-
dures are devised to monitor screening, data collection,
follow-up, clinical measurements, collection of forms,
data entry procedures, and overall scientific and leader-
ship operations.
Discussion
Pneumonia is the leading cause of mortality, morbidity and
transfers to acute care facilities among nursing homes resi-
dents. Nursing home-acquired pneumonia absorbs a large
part of economical resources of the healthcare system [49].
There is growing evidence suggesting that hospitalization
events in residents with nursing home-acquired pneumonia
may also not be clinically relevant, but still responsible for
increased healthcare costs [50]. Unfortunately, clinical re-
search in the nursing home population is still too limited in
this field.
The extremely heterogeneous characteristics of institu-
tionalized older persons make particularly difficult the
design and conduction of specific studies and, at the
same time, almost impossible to directly apply evidence
from different settings. The value of preventive or thera-
peutic strategies commonly adopted in adults is often in-
sufficiently assessed or adequately confirmed/validated
in institutionalized older persons to allow a direct and
unmodified translation of medical guidelines. This issue
may (at least partially) explain the relative reduction of
efficacy for several interventions (including antibiotics)
in nursing homes [51].
Given the multicausal nature of disability, preventive in-
terventions against it should target a wider spectrum of risk
factors potentially inducing (or worsening) the loss of phys-
ical function and health status. Consequently, an effective
program of prevention against disability goes necessarily
through the counteraction of stressors (including acute
conditions, such as pneumonia) capable to disrupt the
already impaired homeostatic equilibrium of frail older per-
sons. In such scenario, preventive interventions (e.g., anti-
pneumococcal vaccines) may gain special relevance, evenbeyond their specific action at the respiratory apparatus
level.
The current limited evidence coming from the nursing
home setting and the modest adherence to current rec-
ommendations represent two major barriers to success-
ful act against disability and its major consequences at
advanced age. Rolland and colleagues [4] already discussed
the reasons for this gap between the theoretical scientific
recommendations and their practical application in the
nursing home clinical routine. For example, data from a
recent study reveal that while most nursing home resi-
dents (about 80%) currenty receive anti-influenza vaccin-
ation, less than one third are instead vaccinated against
pneumococcus [52]. To achieve higher vaccination rates,
the use of Standing Order Program (allowing for vaccin-
ation without an individual physician's order) has even
been proposed as being the most effective and economic-
ally favourable strategy to implement preventive interven-
tions [53]. However, before considering the systematic
implementation of an intervention like this (especially
given the size of the target population) more robust data
are needed. In other words, it is important to carefully and
more comprehensively study the most common condi-
tions of nursing homes, in particular those diseases for
which the efficacy of preventive and/or therapeutical inter-
ventions has already been clearly proven elsewhere. Only
after having obtained data describing the disease charac-
teristics (in terms of prevalence, incidence, consequences)
and the cost-effectiveness of available preventive/thera-
peutical interventions, the extension of these latters may
be correctly planned in the daily clinical routine of nursing
homes. The INCUR project goes indeed in this direction
by 1) describing an almost unknown population, 2) esti-
mating the incidence of a frequent and severely burdening
condition as pneumonia, 3) measuring the effects of such
disease in terms of clinical (for the patient) and econom-
ical (for public health) consequences.
In conclusion, studies are needed to adequately de-
scribe and explore the complex frail older population liv-
ing in nursing homes. The INCUR study will provide
valuable information about the incidence and conse-
quences of a frequent clinical condition (i.e., pneumonia)
in this peculiar subgroup of older persons. The INCUR
study will also support the conduction of sample size
analyses of future trials aimed at evaluating the effects of
preventive/therapeutical interventions against pneumo-
nia in nursing homes. Main results from the INCUR
study are expected for the second half of 2013.
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